MADRIGAL PHARMACEUTICALS, INC. (MDGL) › Cost of RevenueMADRIGAL PHARMACEUTICALS, INC. (MDGL) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2022: $02023: $02024: $6.23M$6.23M2022Cost of Revenue (USD)2024Fiscal YearCost of RevenueChange YoY2024$6.23M—2023$0—2022$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share